Publications by authors named "Marianne Gandee"
Article Synopsis
- Shared decision-making (SDM) is important in healthcare, especially for patients with relapsed and/or refractory multiple myeloma (RRMM), where many treatment options complicate the decision process.
- A study surveyed 200 hematologists/oncologists and 200 RRMM patients to compare their views on treatment decision-making, revealing that both groups prioritize extending overall survival and progression-free survival as key treatment goals.
- The findings highlighted differences in perceptions about decision-making preferences, with more patients favoring a shared role than physicians recognized, indicating a need for improved communication tools to support SDM and patient-centered communication (PCC).
Background: Study populations in clinical research must reflect US changing demographics, especially with the rise of precision medicine. However, racial and ethnic minority groups (REMGs) have low rates of participation in cancer clinical trials.
Methods: Criteria were developed to identify cancer centers able to accrue a higher than average proportion of REMGs into clinical trials.